EdgeMarket › What Rice Hall James & Associates, Llc reported owning
What Rice Hall James & Associates, Llc reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
1.8BPositions
243Quarter
2026-03-31Shown below
50largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | 56.6M | 3.2% | 283.6K | 286.29 | +84.4% |
| FN Fabrinet | 55.2M | 3.1% | 105.8K | 436.67 | +55.8% |
| ARLO Arlo Technologies, Inc. | 52.1M | 2.9% | 3.7M | 13.10 | -21.4% |
| XPO XPO, Inc. | 43.6M | 2.4% | 224.3K | 197.74 | +56.1% |
| ACIW ACI WORLDWIDE, INC. | 41.1M | 2.3% | 1.0M | 51.86 | +10.1% |
| LRN Stride, Inc. | 38.7M | 2.2% | 438.4K | 84.36 | -48.3% |
| FOUR Shift4 Payments, Inc. | 37.1M | 2.1% | 847.7K | 47.93 | -47.0% |
| DFIN Donnelley Financial Solutions, Inc. | 36.8M | 2.0% | 780.0K | 48.23 | -11.1% |
| ASND Ascendis Pharma A/S | 33.9M | 1.9% | 148.4K | 253.29 | +31.4% |
| ZD ZIFF DAVIS, INC. | 33.6M | 1.9% | 799.8K | 56.08 | +56.3% |
| ESTA ESTABLISHMENT LABS HOLDINGS INC. | 31.2M | 1.7% | 548.7K | 72.67 | +85.9% |
| PBH Prestige Consumer Healthcare Inc. | 30.9M | 1.7% | 521.6K | 51.31 | -21.1% |
| KNSA Kiniksa Pharmaceuticals International, plc | 29.3M | 1.6% | 608.4K | 79.03 | +138.0% |
| AWI ARMSTRONG WORLD INDUSTRIES INC | 29.1M | 1.6% | 176.9K | 178.54 | -7.9% |
| YOU Clear Secure, Inc. | 27.9M | 1.6% | 577.1K | 43.29 | +28.9% |
| WEX WEX Inc. | 27.6M | 1.5% | 180.3K | 199.93 | +18.3% |
| WIX Wix.com Ltd. | 26.7M | 1.5% | 296.8K | 82.07 | -35.3% |
| SRAD Sportradar Group AG | 26.5M | 1.5% | 1.6M | 13.00 | -57.1% |
| GDDY GoDaddy Inc. | 26.4M | 1.5% | 319.5K | 97.07 | -33.7% |
| G Genpact LTD | 26.2M | 1.5% | 704.1K | 37.14 | -15.7% |
| ITRN Ituran Location & Control Ltd. | 26.1M | 1.5% | 531.9K | 50.89 | +42.5% |
| MEDP Medpace Holdings, Inc. | 25.9M | 1.4% | 54.0K | 620.75 | +33.3% |
| SUPN SUPERNUS PHARMACEUTICALS, INC. | 24.7M | 1.4% | 477.4K | 45.85 | +7.4% |
| NGVT Ingevity Corp | 24.6M | 1.4% | 345.1K | 70.27 | +28.4% |
| BCRX BIOCRYST PHARMACEUTICALS INC | 21.2M | 1.2% | 2.2M | 9.55 | +14.0% |
| BIRK Birkenstock Holding plc | 21.2M | 1.2% | 590.4K | 35.64 | -28.8% |
| LMAT LEMAITRE VASCULAR INC | 20.2M | 1.1% | 184.7K | 81.86 | -15.4% |
| LKQ LKQ CORP | 20.1M | 1.1% | 685.2K | 25.77 | -15.8% |
| LQDT LIQUIDITY SERVICES INC | 18.3M | 1.0% | 597.2K | 43.27 | +69.6% |
| RDWR RADWARE LTD | 18.0M | 1.0% | 683.3K | 27.85 | +13.3% |
| VRDN Viridian Therapeutics, Inc.\DE | 17.6M | 1.0% | 898.6K | 24.29 | +33.9% |
| AGM FEDERAL AGRICULTURAL MORTGAGE CORP | 17.0M | 0.9% | 114.7K | 220.84 | +12.7% |
| QDEL QuidelOrtho Corp | 16.9M | 0.9% | 1.0M | 14.74 | -44.0% |
| EEFT EURONET WORLDWIDE, INC. | 16.1M | 0.9% | 242.0K | 70.07 | -26.3% |
| DOX AMDOCS LTD | 15.5M | 0.9% | 238.1K | 61.40 | -29.4% |
| unmapped CUSIP 16115Q308 | 15.0M | 0.8% | 72.7K | — | — |
| MTN VAIL RESORTS INC | 15.0M | 0.8% | 116.8K | 152.81 | -0.8% |
| UPWK UPWORK, INC | 14.3M | 0.8% | 1.3M | 8.61 | -39.4% |
| MMS MAXIMUS, INC. | 14.3M | 0.8% | 222.9K | 58.22 | -31.7% |
| NEXN Nexxen International Ltd. | 13.8M | 0.8% | 2.1M | 10.28 | +11.6% |
| ALKS Alkermes plc. | 13.8M | 0.8% | 390.3K | 48.33 | +66.8% |
| ACAD ACADIA PHARMACEUTICALS INC | 13.7M | 0.8% | 617.5K | 29.50 | +18.3% |
| MIRM Mirum Pharmaceuticals, Inc. | 13.6M | 0.8% | 147.0K | 96.31 | +44.4% |
| VREX Varex Imaging Corp | 13.5M | 0.8% | 1.3M | 18.51 | +64.8% |
| NBIX NEUROCRINE BIOSCIENCES INC | 13.2M | 0.7% | 100.0K | 152.57 | +14.5% |
| HROW HARROW, INC. | 13.0M | 0.7% | 368.2K | 40.95 | +7.1% |
| LCII LCI INDUSTRIES | 13.0M | 0.7% | 105.3K | 101.98 | +0.1% |
| CRAI CRA INTERNATIONAL, INC. | 12.2M | 0.7% | 75.4K | 176.90 | -6.8% |
| SSTK Shutterstock, Inc. | 12.2M | 0.7% | 733.7K | 5.32 | -74.9% |
| OZK Bank OZK | 11.9M | 0.7% | 259.6K | 49.42 | -1.3% |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →